Abstract
No public abstract is available from the verified source records.
Paul McNally, Daan Caudri, Jane C Davies, Harm A W M Tiddens
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Impact of 2 years of treatment with elexacaftor/tezacaftor/ivacaftor on longitudinal changes in structural lung disease in people with cystic fibrosis—results from the RECOVER trial
10.1093/annalsats/aaoag021 · 2026
PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis
10.1164/rccm.201501-0061oc · 2015
Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography
10.1002/ppul.23787 · 2017
Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study
10.1016/s2213-2600(25)00248-6 · 2026
No additional external references are available.